National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 3/29/2024 release of VAERS data:

Found 253 cases where Location is U.S., Territories, or Unknown and Vaccine is COVID19 and Manufacturer is JANSSEN and Symptom is Guillain-Barre syndrome

Government Disclaimer on use of this data

Table

   
Age Count Percent
18-29 Years 8 3.16%
30-39 Years 27 10.67%
40-49 Years 36 14.23%
50-59 Years 59 23.32%
60-64 Years 34 13.44%
65-79 Years 30 11.86%
80+ Years 4 1.58%
Unknown 55 21.74%
TOTAL 253 100%



Case Details

This is page 1 out of 26

Result pages: 1 2 3 4 5 6 7 8 9 10   next


VAERS ID: 1133722 (history)  
Form: Version 2.0  
Age: 56.0  
Sex: Male  
Location: Maryland  
Vaccinated: 2021-03-13
Onset: 2021-03-19
   Days after vaccination: 6
Submitted: 0000-00-00
Entered: 2021-03-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / UNK - / -

Administered by: Private       Purchased by: ?
Symptoms: Areflexia, CSF glucose normal, CSF protein increased, CSF red blood cell count, CSF white blood cell count increased, Guillain-Barre syndrome, Hypoaesthesia, Muscular weakness
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalopathy/delirium (broad), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow), Sexual dysfunction (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 2 days
Extended hospital stay? No
Previous Vaccinations:
Other Medications: NAC, Rehmannia 6 supplements and Maca root supplements.
Current Illness: none known
Preexisting Conditions: none known
Allergies: none known
Diagnostic Lab Data: Lumbar puncture (3/23): CSF labs: 3/23/2021: Glucose, CSF 60 mg/dL; Protein,Total, CSF 74.0 mg/dL; Red Blood Count, CSF 21,000 /cu mm; Red Blood Count, CSF 1,000 /cu mm; White Blood Count, CSF 39 /cu mm; White Blood Count, CSF 6 /cu mm
CDC Split Type:

Write-up: Beginning on 3/19 he developed a progressive ascending numbness first in his toes, then progressing to include bilateral legs up to knees and bilateral arms up to mid forearm. He also had mild leg weakness bilaterally. He has absent reflexes. His lumbar puncture showed albuminocytologic dissociation. He was diagnosed with Guillan-Barre syndrome and is being treated with IVIG.


VAERS ID: 1134203 (history)  
Form: Version 2.0  
Age: 55.0  
Sex: Male  
Location: Florida  
Vaccinated: 2021-03-06
Onset: 2021-03-17
   Days after vaccination: 11
Submitted: 0000-00-00
Entered: 2021-03-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / UNK LA / IM

Administered by: Unknown       Purchased by: ?
Symptoms: CSF glucose normal, CSF lymphocyte count normal, CSF neutrophil count increased, CSF protein increased, CSF white blood cell count, Computerised tomogram head normal, Computerised tomogram spine, Guillain-Barre syndrome, Lumbar puncture
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
Extended hospital stay? No
Previous Vaccinations:
Other Medications: None
Current Illness: none
Preexisting Conditions: Prostate cancer Esophageal reflux disease Hypercholesterolemia
Allergies: None
Diagnostic Lab Data: Normal Brain Ct scan Normal Spine Ct scan Lumbar puncture: 4wbc, 12 % neutrophile, 76 % lymphocytes; Protein: 162; Glucose: 61
CDC Split Type:

Write-up: Guillan-Barre syndrome


VAERS ID: 1144847 (history)  
Form: Version 2.0  
Age: 72.0  
Sex: Female  
Location: Virginia  
Vaccinated: 2021-03-08
Onset: 2021-03-15
   Days after vaccination: 7
Submitted: 0000-00-00
Entered: 2021-03-29
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / 1 - / IM

Administered by: Unknown       Purchased by: ?
Symptoms: Guillain-Barre syndrome
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: -Cognitive impairment -Hypercholesterolemia
Allergies: Penicillins
Diagnostic Lab Data:
CDC Split Type:

Write-up: Guillain Barre syndrome


VAERS ID: 1146222 (history)  
Form: Version 2.0  
Age: 61.0  
Sex: Male  
Location: Texas  
Vaccinated: 2021-03-08
Onset: 2021-03-23
   Days after vaccination: 15
Submitted: 0000-00-00
Entered: 2021-03-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1805018 / N/A LA / IM

Administered by: Other       Purchased by: ?
Symptoms: Asthenia, Dysarthria, Facial paralysis, Fall, Gait inability, Guillain-Barre syndrome, Hypoaesthesia, Hypoaesthesia oral, Intensive care, Muscular weakness, Paralysis
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Anticholinergic syndrome (broad), Dystonia (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Accidents and injuries (narrow), Demyelination (narrow), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad), Hearing impairment (broad), Hypoglycaemia (broad), Immune-mediated/autoimmune disorders (narrow), Sexual dysfunction (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 5 days
Extended hospital stay? No
Previous Vaccinations:
Other Medications: Atorvastin Lisinopril Carvedilol
Current Illness: none
Preexisting Conditions: CHF
Allergies: NONE none
Diagnostic Lab Data: unit being monitored--- has been diagnosed with Guillian Barre syndrome awaiting test results and is to receive immunoglobulin intravenously. Possible unable to swallow without aspirating.
CDC Split Type:

Write-up: started getting numbness in hands-fingers and lips and then numbness to feet and fell to ground with inability to walk - no strength in legs knees or arms. left facial drooping and slurring of speech and severe weakness -paralyzed


VAERS ID: 1163209 (history)  
Form: Version 2.0  
Age: 57.0  
Sex: Male  
Location: Connecticut  
Vaccinated: 2021-03-05
Onset: 2021-03-17
   Days after vaccination: 12
Submitted: 0000-00-00
Entered: 2021-04-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / UNK LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Guillain-Barre syndrome, Hypoaesthesia, Paralysis, Pneumonia, Vaccination complication
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Demyelination (narrow), Eosinophilic pneumonia (broad), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (narrow), Immune-mediated/autoimmune disorders (narrow), Sexual dysfunction (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 10 days
Extended hospital stay? No
Previous Vaccinations:
Other Medications: None
Current Illness: None
Preexisting Conditions: None
Allergies: None
Diagnostic Lab Data:
CDC Split Type:

Write-up: Numbness in extremities, paralysis full body. Pneumonia left lung. Now diagnosed with Guillain-Barre syndrome, due to reaction to covid-19 vaccine


VAERS ID: 1166746 (history)  
Form: Version 2.0  
Age: 39.0  
Sex: Female  
Location: Washington  
Vaccinated: 2021-03-14
Onset: 2021-03-26
   Days after vaccination: 12
Submitted: 0000-00-00
Entered: 2021-04-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1805029 / 1 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Asthenia, Guillain-Barre syndrome, Hypoaesthesia, Immunoglobulin therapy, Muscular weakness
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalopathy/delirium (broad), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow), Sexual dysfunction (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
Extended hospital stay? No
Previous Vaccinations:
Other Medications: vitamin D, vitamin B-12
Current Illness:
Preexisting Conditions: depression, vitamin D deficiency
Allergies: no known allergies
Diagnostic Lab Data:
CDC Split Type:

Write-up: Symptoms started as numbness and weakness in her feet which progressed to her hands, and eventually whole body. Diagnosis is Guillain-Barre syndrome. Remains hospitalized and receiving IVIG.


VAERS ID: 1172339 (history)  
Form: Version 2.0  
Age: 59.0  
Sex: Male  
Location: Virginia  
Vaccinated: 2021-03-11
Onset: 2021-03-18
   Days after vaccination: 7
Submitted: 0000-00-00
Entered: 2021-04-06
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1802072 / 1 UN / IM

Administered by: Private       Purchased by: ?
Symptoms: Guillain-Barre syndrome, Hypoaesthesia, Lumbar puncture, Muscular weakness
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalopathy/delirium (broad), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow), Sexual dysfunction (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
Extended hospital stay? No
Previous Vaccinations:
Other Medications: amLODIPine aspirin 81 mg Tablet, diazePAM gabapentin hydroCHLOROthiazide losartan nitroglycerin omeprazole oxyCODONE-acetaminophen potassium chloride SA (K-DUR) tiZANidine
Current Illness:
Preexisting Conditions: Type 2 DM, GERD, Chronic low back pain
Allergies: NKA
Diagnostic Lab Data: Lumbar puncture on 04/03/21
CDC Split Type:

Write-up: A week after the patient had the vaccine he developed weakness with numbness in the lower extremities. Patient continued to get worse and was admitted on 04/03 with concerns for Guillain-Barr? syndrome ( GBS). Patient is currently getting treatment for GBS.


VAERS ID: 1172503 (history)  
Form: Version 2.0  
Age: 69.0  
Sex: Male  
Location: New York  
Vaccinated: 2021-03-11
Onset: 2021-03-25
   Days after vaccination: 14
Submitted: 0000-00-00
Entered: 2021-04-06
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1802072 / 1 RA / -

Administered by: Pharmacy       Purchased by: ?
Symptoms: Asthenia, CSF protein increased, Guillain-Barre syndrome, Lumbar puncture abnormal, White blood cell count decreased
SMQs:, Haematopoietic leukopenia (narrow), Peripheral neuropathy (narrow), Systemic lupus erythematosus (broad), Guillain-Barre syndrome (narrow), Demyelination (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 5 days
Extended hospital stay? No
Previous Vaccinations:
Other Medications: Valsartan-HCTZ, rosuvastain, ASA
Current Illness: None
Preexisting Conditions: HTN, HLD
Allergies: No known allergies
Diagnostic Lab Data: Lumbar puncture with CSF protein 219, WBC 3
CDC Split Type:

Write-up: Patient with progressive ascending weakness over 2 weeks. Diagnosed with Guillain-Barre Syndrome.


VAERS ID: 1181925 (history)  
Form: Version 2.0  
Age: 57.0  
Sex: Male  
Location: Delaware  
Vaccinated: 2021-03-15
Onset: 2021-03-20
   Days after vaccination: 5
Submitted: 0000-00-00
Entered: 2021-04-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1805018 / N/A LA / UN

Administered by: Pharmacy       Purchased by: ?
Symptoms: Back pain, CSF protein, Computerised tomogram, Condition aggravated, Death, Gait disturbance, Guillain-Barre syndrome, Immunoglobulin therapy, Magnetic resonance imaging, Mechanical ventilation, Muscular weakness, Pain, Paraesthesia, X-ray
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Anticholinergic syndrome (broad), Retroperitoneal fibrosis (broad), Parkinson-like events (broad), Acute central respiratory depression (broad), Guillain-Barre syndrome (narrow), Noninfectious encephalopathy/delirium (broad), Demyelination (narrow), Respiratory failure (broad), Hypoglycaemia (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2021-04-06
   Days after onset: 17
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 10 days
Extended hospital stay? No
Previous Vaccinations:
Other Medications: See additional space, Long list.
Current Illness: Car accident on 2/26, so neck and Lumbar pain.
Preexisting Conditions: Heart Failure ~ 2017, Stroke ~ 2019, Hypertension, Diabetes.
Allergies: N/A
Diagnostic Lab Data: I know they did an MRI and a CAT scan, an X-Ray, and they did a protein test on his spinal fluid. He also completed a course of Immunoglobulin therapy for GBS.
CDC Split Type:

Write-up: Patient started complaining of extreme back pain and trouble walking within days after receiving the vaccine. His pain got increasingly worse. On the 23rd he had to be taken into the hospital in an ambulance. He said he felt as if his lower body was separated from his torso, and visible was having trouble walking. They prescribed him Valium, preformed an x-ray, and sent him home. On the 27th he was taken back to the hospital due to leg weakness, tingling in his hands and feet, and extreme pain. He was diagnosed with Guillain-Barre Syndrome. He passed away April 6, 2021 after spending 11 days in the hospital, and 6 days on a ventilator.


VAERS ID: 1182108 (history)  
Form: Version 2.0  
Age: 66.0  
Sex: Female  
Location: Oregon  
Vaccinated: 2021-03-09
Onset: 2021-04-03
   Days after vaccination: 25
Submitted: 0000-00-00
Entered: 2021-04-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / 1 AR / IM

Administered by: Unknown       Purchased by: ?
Symptoms: Areflexia, Facial paralysis, Facial paresis, Guillain-Barre syndrome, Immunoglobulin therapy, Magnetic resonance imaging head abnormal
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious meningitis (broad), Demyelination (narrow), Hearing impairment (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 5 days
Extended hospital stay? No
Previous Vaccinations:
Other Medications: lorazepam prn
Current Illness:
Preexisting Conditions: Anxiety
Allergies: None
Diagnostic Lab Data: MRI brain WWO 4/8/2021: "The subtle enhancement of the 7th and 8th nerve complex is unusual in that it is bilateral. It does, however, correlate with the reported consultation note of Dr. in the electronic medical record. An inflammatory process is favored."
CDC Split Type:

Write-up: Patient developed bilateral facial weakness starting on 4/3/2021, progressed over the course of five days until she presented to the emergency department on 4/8/2021. Exam with bilateral CN VII palsy and lower extremity areflexia. MRI brain shows enhancement of bilateral CN VII and VIII. Suspect GBS, treating with IVIG.


Result pages: 1 2 3 4 5 6 7 8 9 10   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?TABLE=ON&GROUP1=AGE&EVENTS=ON&SYMPTOMS=Guillain-Barre+syndrome+%2810018767%29&VAX=COVID19&VAXMAN=JANSSEN&STATE=NOTFR


Copyright © 2024 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166